NEWS
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
Sonoma Pharmaceuticals (NASDAQ:SNOA) and EMC Pharma have announced a co-marketing agreement to launch and sell an expanded prescription and OTC eye care product line. The collaboration includes:
1. EMC Pharma gaining rights to sell OTC Ocucyn
2. Sonoma gaining rights to sell prescription Acuicyn
3. Introduction of new design and packaging for Ocucyn
4. Presentation of the expanded product line at the American Academy of Ophthalmology's annual meeting in Chicago, October 18-21, 2024
Both products are based on Sonoma's patented Microcyn technology using stabilized hypochlorous acid (HOCl). This partnership aims to increase sales of both OTC and prescription eye care products by coordinating marketing efforts and expanding market reach.
Sonoma Pharmaceuticals (NASDAQ:SNOA) and EMC Pharma have announced a co-marketing agreement to launch and sell an expanded prescription and OTC eye care product line. The collaboration includes:
1. EMC Pharma gaining rights to sell OTC Ocucyn
2. Sonoma gaining rights to sell prescription Acuicyn
3. Introduction of new design and packaging for Ocucyn
4. Presentation of the expanded product line at the American Academy of Ophthalmology's annual meeting in Chicago, October 18-21, 2024
Both products are based on Sonoma's patented Microcyn technology using stabilized hypochlorous acid (HOCl). This partnership aims to increase sales of both OTC and prescription eye care products by coordinating marketing efforts and expanding market reach.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
1403Followers
79Following
10KVisitors
Follow